Skip to main content
| Hans-Günter Meyer-Thompson | Monatliche Neuheiten

'Matters-of-concern' associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative study. 

'Matters-of-concern' associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative study. 

Parkin S, Neale J, Strang J. 

Int J Drug Policy. 2024 Jun 5;129:104470. doi: 10.1016/j.drugpo.2024.104470. Epub ahead of print. PMID: 38843737.

Abstract

https://pubmed.ncbi.nlm.nih.gov/38843737/